John Schmidt leads the UK competition team in London. He has more than two decades of experience dealing with competition authorities and courts in the UK and the EU and regularly advises on complex competition conduct issues, investigations, litigation and merger cases. He has extensive experience advising pharmaceutical and medical device companies on distribution and pricing issues. He has been involved in a large number of pharmaceutical cases both at EU and UK level. Public cases include Perindopril, Modafinil, Paroxetine, Phenytoin, Gaviscon and Mesren as well as a number of pharma procurement cases.
John is dual-qualified in the UK and Germany and has a particular focus on the life sciences, consumer goods, finance and infrastructure sectors.